Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Invivyd Inc. IVVD

Invivyd Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's lead product candidate, ADG20 is developed for the treatment and prevention of coronavirus disease which has demonstrated clinically meaningful results in global Phase 3 clinical trials against multiple variants of concern for the prevention and treatment of COVID-19.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (NDAQ:IVVD)

Fundamentals Snapshot (NDAQ:IVVD)

Opinion & Analysis (NDAQ:IVVD)

No current opinion is available.

Bullboard Posts (NDAQ:IVVD)

ADGI APPOINT DAVID HERING AS INTERIM CEO

EOM
Humanist - February 23, 2022

ADGI:TO ANALYZE DATA FROM TRIALS GLOBALLY/RESULTS END MARCH

BRIEF-Adagio Therapeutics Outlines Strategic Initiatives For Co's ADG20 Program   Published by  Reuters 2022 Feb...
Humanist - February 22, 2022

ADGI CEO RESIGNS/REPLACED BY COO INTERMILY

Adagio Therapeutics Announces CEO Succession Plan   https://finance.yahoo.com/news/adagio-therapeutics-announces-ceo-succession...
Humanist - February 19, 2022

Fekb 09, 2022

Nice price run up and volume. What will 4pm and rest of week say. What are we waiting to say ADGI...
petrojell - February 9, 2022

5 BIOTECH STOCKS WITH MAJOR UPCOMING CATALYSTS

$ADGI $CYTK $PHAT $AGIO $ICPT   Clinical-Stage companies offer an exciting investment opportunity with massive upside potential...
AviseAnalytics - February 8, 2022

any thoughts whats driving adgi tdy?

thx if you're reading this, would welcome all opinions
Humanist - February 7, 2022